Electron microscope shows human respiratory syncytial virus (RSV) virions, colourised blue, and anti-RSV F protein/gold antibodies, colourised yellow, shedding from the surface of human lung cells ...

The risk of respiratory syncytial virus, or RSV, is on the rise, along with that of other illnesses including the flu, stomach flu and COVID-19.

Scientists have been searching for ways to get ahead of RSV as early as 1955 when a virus was discovered in chimpanzees suffering from respiratory symptoms.

Respiratory syncytial virus, or RSV, kills 10,000 to 13,000 older adults annually. Here’s why Dr. Leana Wen recommends people get the new RSV vaccines available for older people, pregnant people ...

Respiratory syncytial virus (RSV) can affect people of all ages. But RSV in babies is most serious. Learn about the symptoms and when to get help.

Pfizer’s vaccine to protect newborns from respiratory syncytial virus, or RSV, by vaccinating their moms late in pregnancy cuts the risk that infants will need to see a doctor or be admitted to ...

Respiratory syncytial virus (RSV) is a virus that leads to a mild infection. It causes symptoms that are very similar to the common cold.

Respiratory syncytial virus, or RSV, is a common virus that infects the nose, throat and lungs, according to the U.S. Centers for Disease Control and Prevention. Is it RSV, COVID or the flu?

On top of continued concerns about COVID-19 and the anticipated wave of flu cases this fall and winter, health experts are also confronting another infectious disease: Respiratory syncytial virus ...

And for the last few months, patients with a different malady — respiratory syncytial virus, known as RSV — have been overwhelming hospitals.

Symptoms for respiratory syncytial virus include coughing, wheezing, runny nose and decreased appetite.